Insider · CIK 0001014330

FIELDS HEIDI

Reports to the SEC for 6 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001014330

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+24.1K sh	—	—	54,122
2025-06-03	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+10.5K sh	—	—	30,000
2025-06-03	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2025-03-14	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,819 sh	$121.18	+$220K	58,851.252
2024-05-23	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	−17.5K sh	—	—	17,500
2024-05-23	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+10.5K sh	—	—	19,500
2024-03-15	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,678 sh	$147.48	+$247K	56,653.664
2024-03-05	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−1,658 sh	$144.34	−$239K	54,975.664
2024-02-19	Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−25.3K sh	—	—	0
2024-02-19	Icosavax, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−2,917 sh	—	—	0
2024-02-19	Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−22.3K sh	—	—	0
2024-02-19	Icosavax, Inc.U Disposition from Tender	See Remarks	UDisposition from Tender	−11.4K sh	—	—	0
2024-02-19	Icosavax, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−17K sh	—	—	0
2023-06-06	Icosavax, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+17K sh	—	—	17,000
2023-05-25	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-25	PHATPhathom Pharmaceuticals, Inc.A Award	Director	AAward	+9,000 sh	—	—	9,000
2023-03-16	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,658 sh	$136.82	+$227K	56,221.592
2022-11-23	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−3,635 sh	$155.84	−$566K	54,484.145
2022-06-10	Icosavax, Inc.Stock Option (Right to Buy))A Award	See Remarks	AAward	+22.3K sh	—	—	22,278
2022-06-10	Icosavax, Inc.A Award	See Remarks	AAward	+5,543 sh	—	—	14,293
2022-05-25	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-03-17	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,785 sh	$136.82	+$244K	57,849.692
2021-07-30	Icosavax, Inc.A Award	See Remarks	AAward	+8,750 sh	$15.00	+$131K	8,750
2021-05-21	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-03-18	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+1,850 sh	$121.59	+$225K	55,767.619
2021-01-04	AVNSAVANOS MEDICAL, INC.A Award	Director	AAward	+4,005 sh	—	—	28,855
2020-06-04	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−10.4K sh	$91.00	−$946K	130.081
2020-06-04	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−10.4K sh	$91.00	−$946K	0
2020-05-21	PHATPhathom Pharmaceuticals, Inc. · Stock OptionsA Award	Director	AAward	+10K sh	—	—	10,000
2020-04-17	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+3,081 sh	$73.01	+$225K	10,392
2020-01-02	AVNSAVANOS MEDICAL, INC.A Award	Director	AAward	+5,293 sh	—	—	24,850
2019-09-20	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−4,000 sh	$78.56	−$314K	7,311
2019-08-30	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−200 sh	$70.97	−$14.2K	11,511
2019-08-30	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−500 sh	$70.97	−$35.5K	11,711
2019-08-30	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−200 sh	$70.97	−$14.2K	11,311
2019-08-30	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−3,100 sh	$70.96	−$220K	12,211
2019-03-21	AAGILENT TECHNOLOGIES, INC.A Award	Director	AAward	+2,823 sh	$82.00	+$231K	15,311
2019-01-02	AVNSAVANOS MEDICAL, INC.A Award	Director	AAward	+4,248 sh	—	—	19,557
2018-09-11	AAGILENT TECHNOLOGIES, INC. · Non-Employee Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,482 sh	—	—	0
2018-09-11	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−5,482 sh	$67.73	−$371K	52,802.494
2018-09-11	AAGILENT TECHNOLOGIES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,482 sh	$13.89	+$76.1K	58,284.494
2018-07-19	Financial Engines, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−21.3K sh	$45.00	−$958K	0
2018-07-19	Financial Engines, LLCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,224 sh	—	—	0
2018-07-19	Financial Engines, LLCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,517 sh	—	—	0
2018-07-19	Financial Engines, LLCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,567 sh	—	—	0
2018-07-19	Financial Engines, LLCEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2018-07-19	Financial Engines, LLCEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2018-07-19	Financial Engines, LLCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,482 sh	—	—	0
2018-07-19	Financial Engines, LLCEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2018-06-11	AAGILENT TECHNOLOGIES, INC.S Sale	Director	SSale	−5,000 sh	$66.47	−$332K	52,682.453

Recent filings

Accepted (ET)
May 214
FIELDS HEIDI0001193125-26-234567
SEC(opens sec.gov)
Jun 54
FIELDS HEIDI0000950170-25-082453
SEC(opens sec.gov)
Mar 184
FIELDS HEIDI0001127602-25-009722
SEC(opens sec.gov)
May 244
FIELDS HEIDI0000950170-24-064826
SEC(opens sec.gov)
Mar 194
FIELDS HEIDI0001127602-24-010684
SEC(opens sec.gov)
Mar 74
FIELDS HEIDI0001127602-24-008947
SEC(opens sec.gov)
Feb 204
FIELDS HEIDI0000950170-24-017415
SEC(opens sec.gov)
Jun 84
FIELDS HEIDI0001209191-23-035448
SEC(opens sec.gov)
May 304
FIELDS HEIDI0001209191-23-033013
SEC(opens sec.gov)
Mar 204
FIELDS HEIDI0000899243-23-009213
SEC(opens sec.gov)
Nov 284
FIELDS HEIDI0001127602-22-026417
SEC(opens sec.gov)
Jun 144
FIELDS HEIDI0001209191-22-036740
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932